loadpatents
name:-0.010761022567749
name:-0.020631074905396
name:-0.0019230842590332
Teng; Nelson N. H. Patent Filings

Teng; Nelson N. H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Teng; Nelson N. H..The latest application filed is for "cdim binding proteins and uses thereof".

Company Profile
0.18.7
  • Teng; Nelson N. H. - Hillsborough CA
  • Teng; Nelson N. H. - Millsborough CA
  • Teng; Nelson N. H. - Palo Alto CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Antibody induced cell membrane wounding
Grant 9,458,241 - Bhat , et al. October 4, 2
2016-10-04
CDIM binding proteins and uses thereof
Grant 9,409,976 - Teng , et al. August 9, 2
2016-08-09
CDIM Binding Proteins And Uses Thereof
App 20140044739 - Teng; Nelson N. H. ;   et al.
2014-02-13
Antibody induced cell membrane wounding
App 20130164283 - Bhat; Neelima M ;   et al.
2013-06-27
Antibody induced cell membrane wounding
Grant 8,377,435 - Bhat , et al. February 19, 2
2013-02-19
Enhanced B Cell Cytotoxicity Of Cdim Binding Antibody
App 20120237441 - Bhat; Neelima M. ;   et al.
2012-09-20
Enhanced B Cell Cytotoxicity Of Cdim Binding Antibody
App 20100322849 - Bhat; Neelima M. ;   et al.
2010-12-23
Antibody induced cell membrane wounding
App 20060153854 - Bhat; Neelima M. ;   et al.
2006-07-13
Enhanced B cell cytotoxicity of CDIM binding antibody
App 20050112130 - Bhat, Neelima M. ;   et al.
2005-05-26
Method of killing B cells using antibodies which bind CDIM
Grant 5,593,676 - Bhat , et al. January 14, 1
1997-01-14
Triple gradient process with antibody panning to recover nucleated fetal cells from maternal blood
Grant 5,437,987 - Teng , et al. August 1, 1
1995-08-01
Method of killing B-cells in a complement independent and an ADCC independent manner using antibodies which specifically bind CDIM
Grant 5,417,972 - Bhat , et al. May 23, 1
1995-05-23
Reagents and kits for determination of fetal fibronectin in a vaginal sample
Grant 5,281,522 - Senyei , et al. January 25, 1
1994-01-25
Triple gradient process for recovering nucleated fetal cells from maternal blood
Grant 5,275,933 - Teng , et al. January 4, 1
1994-01-04
Ectopic pregnancy test
Grant 5,236,846 - Senyei , et al. * August 17, 1
1993-08-17
Ex vivo product of conception test to determine abortion
Grant 5,223,440 - Teng , et al. June 29, 1
1993-06-29
Fetal fibronectin pregnancy test
Grant 5,185,270 - Senyei , et al. February 9, 1
1993-02-09
Adenocarcinoma antigen binding methods and reagents
Grant 5,118,611 - Smith , et al. June 2, 1
1992-06-02
Preterm labor and membrane rupture test
Grant 5,096,830 - Senyei , et al. March 17, 1
1992-03-17
Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin
Grant 5,079,171 - Senyei , et al. January 7, 1
1992-01-07
Sample collection and transport fluid composition
Grant 4,919,889 - Jones , et al. April 24, 1
1990-04-24
Methods and cell lines for immortalization and monoclonal antibody production by antigen-stimulated B-lymphocytes
Grant 4,574,116 - Kaplan , et al. March 4, 1
1986-03-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed